Helmerich & Payne (NYSE:HP) Stock, Quote.Headers.trade-ideas

Helmerich & Payne

Helmerich & Payne maintains one of the largest fleets of land drilling rigs in the US. The company's FlexRig line is the leading choice to drill horizontal wells for production of US tight oil and gas. H&P is present in nearly every major US shale play and has a small but growing presence internationally.

Movers

News

Intraday Update

Markets

Trading Ideas

ASTS

ATPC

BALY

BLMZ

CERO

COOP

CTNT

EZFL

FORM

GSHD

HOTH

INDV

JBHT

KALU

KDLY

LULU

PEGA

PLXS

POAI

RBBN

SHYF

SLGL

SLNA

SLRX

STLA

TIVC

TWOU

VKTX

XCUR

Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Business,Man,Sign,A,Contract,Investment,Professional,Document,Agreement.,Meeting

Equities

Mid Cap

PSCE

SPDR S&P Oil & Gas Equipment & Services ETF

Helmerich &amp; Payne acquires KCA Deutag for $1.9725 billion, expanding its Middle East operations and boosting cash flow.

Helmerich &amp; Payne Makes Big Bet on Middle East with ~$2B KCA Deutag Acquisition

IBM Investment

BEAM

CBRE

MORN

NDAQ

VSAT

IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich &amp; Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday

Helmerich & Payne Inc

Henley Park Acquisition Corp

CHINA HIGH PRCSN AUTOMT by CHINA HIGH PRECISION AUTOMATION GROUP LIMITED

China High Precision Automation Group Ltd

Helport AI Ltd

HSBC MSCI ASA PAC EX JPN PAB UCT ETF

HSBC MSCI USA CLIMATE PARIS UCIT ETF

HSBC MSCI WORLD CLMATE PARS UCIT ETF

High Performance Blockchain

Hempacco Co Inc

HOME PRODS CNTR PCL FGN by Home Products Center Public Co., Ltd.

Home Product Center PCL

Home Product Center PCL Units Non-voting Depository Receipt

HOPSON DEVELOPMENT HLDG by Hopson Development Holdings Ltd.

Hopson Development Holdings Ltd

Hewlett Packard Enterprise Company Common Stock

Hewlett Packard Enterprise Co

HSBC FTSE EPRA NAR DEV CPA ETF USD

HSBC MSCI EM PAB UCITS ETF

Hewlett Packard Enterprise Company 7.625% Series C Mandatory Convertible Preferred Stock

John Hancock Pfd Income Fund II Pfd Income Fund II

John Hancock Preferred Income Fund II

HRVST ENRG LDR PLS INCM CL U UNT ETF

Hapag-Lloyd AG

Highest Performances Holdings Inc. - American Depository Shares

Highest Performances Holdings Inc

HAMAMATSU PHOTONICS ORD by Hamamatsu Photonics

Hamamatsu Photonics KK

HAMAMATSU PHOTONICS ADR by Hamamatsu Photonics

John Hancock Preferred Income Fund Common Shares of Beneficial Interest

John Hancock Preferred Income Fund

HUADIAN PWR INTL CORP ORD by Huadian Power International Corp.

Huadian Power International Corp Ltd

HUADIAN PWR INTL UNSP/ADR by Huadian Power International Corp.

HPIL Holding

HSBC MSCI JAPAN CLIMATE PARIS UCITS ETF

HighPeak Energy Inc

HORIZON PETROLEUM LTD by Horizon Pete Ltd

Horizon Petroleum Ltd

HOSKEN PASSENGER LOGISTIC by HOSKEN PASSENGER LOGISTICS & RAIL LTD.

Frontier Transport Holdings Ltd

AFRICA ENERGY CORP by Africa Energy Corp.

Africa Energy Corp

Hemp Naturals Inc

Hop-On Inc

Hudson Pacific Properties, Inc. Common Stock

Hudson Pacific Properties Inc

Hudson Pacific Properties, Inc. 4.750% Series C Cumulative Redeemable Preferred Stock

HP Inc

HPQ Silicon Inc

HSBC FTSE EPRA NAREIT DEV ETF USD

HSBC FTSE EPRA/NAREIT DEV. UCITS ETF

John Hancock Preferred Income Fund III Preferred Income Fund III

John Hancock Preferred Income Fund III

HYBRID PWR SOLUTIONS INC by Hybrid Power Solutions Inc.

Hybrid Power Solutions Inc

Hempstract Inc

Huobi Pool Token

HAPPY TOWN HOLDINGS by Happy Town Holdings Inc.

Happy Town Holdings Inc

hopTo Inc

HSBC MSCI USA CL PAR ALGN ETF USD

HOPIUM SA by HOPIUM SA

Hexagon Purus ASA

HAPPY CREEK MINERALS LTD by Happy Creek Minerals Ltd.

Happy Creek Minerals Ltd

HARVST PRM YLD 7 10 YR TSRY UNT ETF

HARVEST PREMIUM YIELD TRSRY UNT ETF

Citigroup analyst Scott Gruber maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Neutral and lowers the price target from $41 to $33.

Price Target

Analyst Ratings

Citigroup Maintains Neutral on Helmerich & Payne, Lowers Price Target to $33

Senior notes, comprised of the following tranches (collectively, the &quot;Notes&quot;):&nbsp;$350 million&nbsp;aggregate principal amount of&nbsp;4.650%&nbsp;senior notes due 2027 to be issued at a price equal to&nbsp;99.958%&nbsp;of their face value,&nbsp;$350 million&nbsp;aggregate principal amount of&nbsp;4.850%&nbsp;senior notes due 2029 to be issued at a price equal to&nbsp;99.883%&nbsp;of their face value and&nbsp;$550 million&nbsp;aggregate principal amount of&nbsp;5.500%&nbsp;senior notes due 2034 to be issued at a price equal to&nbsp;99.670%&nbsp;of their face value.
The Company intends to use the net proceeds from the Offering, together with the proceeds of its term loan credit facility and cash on hand, to finance the purchase price for its previously announced pending acquisition (the &quot;Acquisition&quot;) of KCA Deutag International Limited (&quot;KCAD&quot;), to repay certain of KCAD&#39;s outstanding indebtedness, and to pay related fees and expenses. The net proceeds from the Offering will reduce the commitments under the Company&#39;s existing bridge loan facility for purposes of financing the Acquisition to approximately&nbsp;$332 million.

Reported Earlier, Helmerich & Payne Prices $1.25B Senior Notes, Including $550M Due in 2034, To Support Corporate Initiatives

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Helmerich &amp; Payne and provided 12-month price targets. The average target is $40.0, accompanied by a high estimate of $50.00 and a low estimate of $34.00. A decline of 4.49% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1724943654_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A clear picture of Helmerich &amp; Payne's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neil Mehta</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$34.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Keith Mackey</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$50.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Chase Mulvehill</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$40.00</td>
<td>$42.50</td>
</tr>
<tr>
<td>Ian Macpherson</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$36.00</td>
<td>$39.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Helmerich &amp; Payne. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Helmerich &amp; Payne compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Helmerich &amp; Payne's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Helmerich &amp; Payne's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/HP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Helmerich &amp; Payne analyst ratings.</a>
<h2>Unveiling the Story Behind Helmerich &amp; Payne</h2>
Helmerich &amp; Payne maintains one of the largest fleets of land drilling rigs in the US. The company's FlexRig line is the leading choice to drill horizontal wells for production of US tight oil and gas. H&amp;P is present in nearly every major US shale play and has a small but growing presence internationally.
<h3>Understanding the Numbers: Helmerich &amp; Payne's Finances</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Challenges: Helmerich &amp; Payne's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -3.62%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Helmerich &amp; Payne's net margin is impressive, surpassing industry averages. With a net margin of 12.54%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Helmerich &amp; Payne's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.09%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Helmerich &amp; Payne's ROA stands out, surpassing industry averages. With an impressive ROA of 1.96%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Helmerich &amp; Payne's debt-to-equity ratio is below the industry average at 0.19, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Unveiling 4 Analyst Insights On Helmerich & Payne

Goldman Sachs analyst Neil Mehta maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Sell and lowers the price target from $38 to $34.

Goldman Sachs Maintains Sell on Helmerich & Payne, Lowers Price Target to $34

Management

Helmerich & Payne Announces Hiring Of Kevin Vann As CFO

WIIM

AROC

CEIX

CRGY

CTRA

DWSN

EQNR

FANG

LBRT

LODE

MTDR

PTEN

RCON

REPX

SDRL

SHEL

TOPS

TRGP

WFRD

Shares of oil and gas companies are trading lower. The sector might be moving amid overall market weakness due to economic slowdown concerns following recent US data, which could negatively impact demand.

In the preceding three months, 3 analysts have released ratings for Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>), presenting a wide array of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $42.0, along with a high estimate of $50.00 and a low estimate of $36.00. This current average represents a 2.71% decrease from the previous average price target of $43.17. 
<img src="https://www.benzinga.com/files/images/story/2024/1722862836_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Helmerich &amp; Payne among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Keith Mackey</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$50.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Chase Mulvehill</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$40.00</td>
<td>$42.50</td>
</tr>
<tr>
<td>Ian Macpherson</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$36.00</td>
<td>$39.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Helmerich &amp; Payne. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Helmerich &amp; Payne compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Helmerich &amp; Payne's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Helmerich &amp; Payne's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Helmerich &amp; Payne analyst ratings.</a>
<h2>All You Need to Know About Helmerich &amp; Payne</h2>
Helmerich &amp; Payne maintains one of the largest fleets of land drilling rigs in the US. The company's FlexRig line is the leading choice to drill horizontal wells for production of US tight oil and gas. H&amp;P is present in nearly every major US shale play and has a small but growing presence internationally.
<h3>Helmerich &amp; Payne's Financial Performance</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Helmerich &amp; Payne's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -3.62%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.
Net Margin: Helmerich &amp; Payne's net margin is impressive, surpassing industry averages. With a net margin of 12.54%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.09%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.96%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.19, Helmerich &amp; Payne adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 3 Analysts Discuss Helmerich & Payne Stock

Benchmark analyst Kurt Hallead reiterates Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Hold.

Reiteration

Benchmark Reiterates Hold on Helmerich & Payne

ACDC

AESI

ARCH

BANL

BORR

CHRD

CLMT

DINO

GLNG

GPRK

LTBR

TALO

VIST

VNOM

WTTR

Shares of oil and gas stocks are trading lower despite Middle East tensions. Weak US economic data may be weighing on demand outlook.

Shares of oil and gas stocks are trading lower. Weakness in the sector may be due to wore-than-expected US economic data, which could pressure demand outlook.

RBC Capital analyst Keith Mackey maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Sector Perform and raises the price target from $48 to $50.

RBC Capital Maintains Sector Perform on Helmerich & Payne, Raises Price Target to $50

Shares of Edwards Lifesciences Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) fell sharply during Thursday's session after the company reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired <a href="https://www.benzinga.com/quote/EW/earnings">JenaValve and Endotronix</a>.
Edwards Lifesciences reported quarterly earnings of 70 cents per share which beat the analyst consensus estimate of 69 cents per share. The company reported quarterly sales of $1.632 billion which missed the analyst consensus estimate of $1.653 billion.
Edwards Lifesciences shares dipped 26.9% to $63.60 on Thursday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Predictive Oncology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POAI#NASDAQ">POAI</a>) shares jumped 85% to $1.96 after the company entered biomarker discovery market after successful retrospective ovarian cancer study yields compelling results.</li>
<li>Psyence Biomedical Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBM#NASDAQ">PBM</a>) rose 65.4% to $0.6424 after the company announced the export of nature-derived psilocybin to Australia and said a trial is projected to be initiated shortly following receipt of drug product by trial sites.</li>
<li>Salarius Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) jumped 60% to $3.4421.</li>
<li>Goosehead Insurance, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) rose 29.8% to $85.25 following upbeat second-quarter results.</li>
<li>Viking Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) shares gained 28.2% to $64.64 after the company reported better-than-expected second-quarter EPS results.</li>
<li>Exicure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) rose 27% to $0.5090.</li>
<li>CERo Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) gained 25.4% to $0.2645 after gaining around 8% on Wednesday.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) rose 25.2% to $16.72. The company announced the successful completion of its first five commercial satellites.</li>
<li>Bally&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALY#NYSE">BALY</a>) gained 24.2% to $16.80. Bally&#8217;s entered into merger agreement with affiliates of Standard General L.P.</li>
<li>Molina Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) climbed 18.3% to $341.39 following better-than-expected quarterly earnings.</li>
<li>The Shyft Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHYF#NASDAQ">SHYF</a>) gained 16.4% to $13.55 following upbeat earnings.</li>
<li>Carpenter Technology Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) climbed 16.3% to $141.59 after the company reported better-than-expected quarterly financial results.</li>
<li>Indivior PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDV#NASDAQ">INDV</a>) rose 15.4% to $12.56 after the company posted better-than-expected second-quarter results and announced an accelerated $100 million share repurchase program.</li>
<li>Tivic Health Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) shares climbed 15.4% to $0.3499.</li>
<li>RPC, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RES#NYSE">RES</a>) gained 15.1% to $6.64 following upbeat earnings.</li>
<li>ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) jumped 13.7% to $831.97 after the company reported better-than-expected second-quarter financial results.</li>
<li>Pegasystems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) rose 13.1% to $69.09 after the company reported better-than-expected second-quarter financial results.</li>
<li>Helmerich &amp; Payne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) climbed 12.5% to $42.46 following third-quarter results.</li>
<li>BloomZ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) gained 12.2% to $2.75 after dipping 43% on Wednesday. BloomZ recently priced its IPO at $4.30 per share.</li>
<li>Valmont Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) gained 11.1% to $300.96 following upbeat earnings.</li>
<li>Plexus Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) rose 10.5% to $128.36 following upbeat earnings.</li>
<li>Knight-Swift Transportation Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) rose 10.1% to $53.92 following second-quarter results.</li>
<li>Tyler Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) gained 9.6% to $565.64 after the company reported better-than-expected second-quarter adjusted EPS and sales.</li>
<li>Mr. Cooper Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NYSE">COOP</a>) rose 9.5% to $94.86 following second-quarter results.</li>
<li>Oceaneering International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OII#NYSE">OII</a>) gained 9.2% to $27.79 following strong sales.</li>
<li>RTX Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) surged 8% to $113.24 following a second-quarter earnings beat.</li>
<li>J.B. Hunt Transport Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) gained 6.1% to $173.75.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>2U, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWOU#NASDAQ">TWOU</a>) shares dipped 60% to $1.65. 2U announced a strategic agreement with debtholders to eliminate half of debt and infuse $110 million in new capital.</li>
<li>EZFill Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZFL#NASDAQ">EZFL</a>) tumbled 40.3% to $3.73.</li>
<li>Kindly MD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDLY#NASDAQ">KDLY</a>) fell 37.5% to $2.04 after the company submitted comment to the Department of Justice regarding cannabis rescheduling.</li>
<li>Cheetah Net Supply Chain Service Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNT#NASDAQ">CTNT</a>) dipped 34% to $0.3185. Cheetah Net Supply Chain Service announced pricing of $1.49 million follow-on public offering.</li>
<li>MaxLinear, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NYSE">MXL</a>) shares fell 30.7% to $15.45 after the company reported worse-than-expected second-quarter financial results.</li>
<li>Sol-Gel Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLGL#NASDAQ">SLGL</a>) dipped 30% to $0.4750. Sol-Gel announced the signing of six exclusive license agreements to commercialize TWYNEO&#xAE; and EPSOLAY&#xAE; in Europe and South Africa.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) fell 29.7% to $9.49 after declining 10% on Wednesday.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) fell 27% to $0.1159.</li>
<li>Orion Group Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORN#NYSE">ORN</a>) declined 21.9% to $8.62 after the company reported worse-than-expected second-quarter financial results.</li>
<li>Ostin Technology Group Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) shares declined 20.3% to $0.35 after gaining around 19% on Wednesday.</li>
<li>Ribbon Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBBN#NASDAQ">RBBN</a>) tumbled 19.2% to $3.1450 after the company reported worse-than-expected quarterly revenue.</li>
<li>Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) shares fell 16.6% to $11.40 following a second-quarter earnings miss.</li>
<li>Hoth Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOTH#NASDAQ">HOTH</a>) fell 15.1% to $0.9103. Hoth Therapeutics shares gained around 11% on Wednesday after the company signed an agreement with LTS Therapy Systems to develop and manufacture the HT-ALZ oral film prototype for Alzheimer&#8217;s disease.</li>
<li>Garrett Motion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTX#NASDAQ">GTX</a>) declined 13.8% to $7.86 after the company reported worse-than-expected quarterly financial results and lowered its FY24 guidance.</li>
<li>Selina Hospitality PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) shares fell 13.4% to $0.0396 after jumping over 75% on Wednesday.</li>
<li>Kaiser Aluminum Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALU#NASDAQ">KALU</a>) declined 13.3% to $79.76 after the company reported worse-than-expected quarterly financial results.</li>
<li>Hut 8 Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NYSE">HUT</a>) declined 12.8% to $15.71.</li>
<li>LKQ Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>) fell 12.1% to $39.10 after the company reported worse-than-expected quarterly adjusted EPS and sales. Additionally, the company lowered its FY24 adjusted EPS outlook.</li>
<li>STMicroelectronics N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STM#NYSE">STM</a>) shares fell 12% to $34.81 after the company reported a second-quarter EPS miss and issued soft third-quarter guidance.</li>
<li>Teradyne, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) dipped 9.7% to $129.30 following soft third-quarter guidance.</li>
<li>West Pharmaceutical Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) fell 9.5% to $292.91 after the company reported a quarterly earnings miss and cut its guidance.</li>
<li>FormFactor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) fell 8.2% to $52.26.</li>
<li>Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) tumbled 8.2% to $249.52 after Citigroup downgraded the stock from a Buy to a Neutral and lowered its price target from $415 to $300.</li>
<li>Robert Half Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHI#NYSE">RHI</a>) declined 7% to $60.32 after the company reported worse-than-expected second-quarter financial results.</li>
<li>Stellantis N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) fell 6.8% to $18.27 following H1 results.</li>
<li>QuantumScape Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) shares fell 6.2% to $7.01 after the company reported worse-than-expected EPS results.</li>
<li>Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) declined 4.1% to $204.82 after the company lowered FY24 EPS guidance.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39961297/this-lululemon-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-thursday">This Lululemon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday</a></li>
</ul>

Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Helmerich &amp; Payne, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) shares are trading higher today. The company disclosed the acquisition of KCA Deutag <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b39955853/helmerich-payne-announces-agreement-to-acquire-kca-deutag" rel="noreferrer noopener">for $1.9725 billion in cash</a>.
KCA Deutag is a drilling company with a land drilling presence in the Middle East. The acquisition grants Helmerich substantial entry into land operations in the region, where KCA Deutag earned about 70% of its 2023 Operating EBITDA.
The transaction is expected to close before the end of calendar year 2024, pending customary closing conditions.
Post-acquisition, Helmerich&#8217;s Middle East rig count will jump from 12 to 88, with 71 rigs in Saudi Arabia, Oman, and Kuwait, making it one of the region&#8217;s largest rig providers.
The Middle East rig market is projected to grow, and with KCA Deutag&#8217;s ~$5.5 billion contract backlog and strong customer base, H&amp;P will gain resilient revenues and improved earnings visibility.
Synergies: H&amp;P expects this transaction to grow its international land operations from ~1%&nbsp;on a standalone basis to ~19%&nbsp;on a pro forma basis based on calendar year 2023 Operating EBITDA, and also its offshore operations will rise from ~3% to ~7%.
The combined company&#8217;s last-twelve months Operating EBITDA stands at approximately $1.2 billion.
The transaction is anticipated to be immediately accretive to cash flow and free cash flow per share, with double-digit free cash flow accretion expected by 2025. Returns are projected to surpass the cost of capital by 2026.
Despite the minimal geographic overlap, Helmerich anticipates achieving ~$25 million in run-rate synergies by 2026, mainly from overhead <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">reductions and procurement savings</a>.
Post-closure, H&amp;P will have three main operating segments: North America Solutions, International Solutions, and Offshore Solutions, with North America Solutions remaining unchanged.
Yesterday, the company reported third-quarter adjusted EPS of&nbsp;$0.92, above the consensus of&nbsp;$0.77, and revenue&nbsp;of $698 million, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b39943466/helmerich-payne-inc-announces-fiscal-third-quarter-results" rel="noreferrer noopener">beating the street view.</a>
As of June 30, the company&#8217;s cash and cash equivalent stood at $203.6 million.
Investors can gain exposure to the stock via Invesco S&amp;P SmallCap Energy ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSCE#NASDAQ">PSCE</a>) and SPDR Series Trust SPDR S&amp;P Oil &amp; Gas Equipment &amp; Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XES#NYSE">XES</a>).
Price Action: HP shares are up 10.4% at $41.70 at the last check Thursday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Shutterstock

Helmerich & Payne Makes Big Bet on Middle East with ~$2B KCA Deutag Acquisition

U.S. stocks were higher, with the Dow Jones index gaining more than 1% on Thursday.
Shares of International Business Machines Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) rose during Thursday's session following strong <a href="https://www.benzinga.com/news/24/07/39961144/why-ibm-stock-is-trading-higher-on-thursday">quarterly earnings</a>.
IBM reported quarterly earnings of $2.43 per share, which beat the analyst consensus estimate of $2.19. Quarterly sales clocked in at $15.8 billion, which beat the analyst consensus estimate of $15.616 billion.
IBM shares gained 6.4% to $195.75 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Viking Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) shares surged 28.2% to $64.64 after the company reported better-than-expected second-quarter EPS results.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) jumped 25.2% to $16.72. The company announced the successful completion of its first five commercial satellites.</li>
<li>Bally&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALY#NYSE">BALY</a>) shares rose 24.2% to $16.80. Bally&#8217;s entered into merger agreement with affiliates of Standard General L.P.</li>
<li>Molina Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) gained 18.3% to $341.39 following better-than-expected quarterly earnings.</li>
<li>Carpenter Technology Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) jumped 16.3% to $141.59 after the company reported better-than-expected quarterly financial results.</li>
<li>RPC, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RES#NYSE">RES</a>) rose 15.1% to $6.64 following upbeat earnings.</li>
<li>ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) rose 13.7% to $831.97 after the company reported better-than-expected second-quarter financial results.</li>
<li>Viasat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) jumped 13.6% to $19.05.</li>
<li>Pegasystems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) gained 13.1% to $69.09 after the company reported better-than-expected second-quarter financial results.</li>
<li>Helmerich &amp; Payne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) gained 12.5% to $42.46 following third-quarter results.</li>
<li>CBRE Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBRE#NYSE">CBRE</a>) surged 11.7% to $109.87 after the company raised its 2024 guidance.</li>
<li>Valmont Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) climbed 11.1% to $300.96 following upbeat earnings.</li>
<li>Lazard, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) rose 11% to $48.08 following better-than-expected quarterly earnings.</li>
<li>Tyler Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) rose 10.7% to $571.01 after the company reported better-than-expected quarterly adjusted EPS and sales.</li>
<li>Plexus Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) gained 10.5% to $128.36 following upbeat earnings.</li>
<li>Transocean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) surged 10.2% to $5.80.</li>
<li>Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) rose 10.1% to $32.81.</li>
<li>Knight-Swift Transportation Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) gained 10.1% to $53.92 following second-quarter results.</li>
<li>Tyler Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) shares climbed 9.6% to $565.64 after the company reported better-than-expected second-quarter adjusted EPS and sales.</li>
<li>Mr. Cooper Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NYSE">COOP</a>) gained 9.5% to $94.86 following second-quarter results.</li>
<li>RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) climbed 9.2% to $121.14 after the company reported better-than-expected quarterly earnings.</li>
<li>Oceaneering International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OII#NYSE">OII</a>) rose 9.2% to $27.79 following strong sales.</li>
<li>Masco Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>) gained 8.1% to $76.27 after the company reported better-than-expected second-quarter earnings.</li>
<li>Universal Health Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) rose 8.1% to $201.00 after the company reported better-than-expected second-quarter earnings and increased FY 2024 guidance.</li>
<li>RTX Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) climbed 8% to $113.24 following a second-quarter earnings beat.</li>
<li>Morningstar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MORN#NASDAQ">MORN</a>) rose 7.8% to $328.71. The company reported second-quarter financial results yesterday.</li>
<li>Nasdaq, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) gained 7.4% to $67.36 after the company reported better-than-expected second-quarter financial results.</li>
<li>MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) rose 7.4% to $262.60.</li>
<li>J.B. Hunt Transport Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) shares rose 6.1% to $173.75.</li>
<li>Unilever PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UL#NYSE">UL</a>) gained 5.9% to $59.90 following HI results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39961795/apple-to-rally-around-10-here-are-10-top-analyst-forecasts-for-thursday">Apple To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday</a></li>
</ul>

IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday

Helmerich & Payne shares are trading higher after the company reported better-than-expected Q3 financial results. Also, the company announced an agreement to acquire KCA Deutag in a $1.97B cash deal.

<ul>
<li>Establishes H&amp;P as a global leader in onshore drilling</li>
<li>Immediately accretive to cash flow and free cash flow per share</li>
<li>Enhances scale and diversification, now with leading positions in the U.S. and Middle East, the two most prominent oil and gas producing regions in the world</li>
<li>Increases H&amp;P's Middle East rig count(1) from 12 rigs to 88 rigs; positioning the Company as one of the largest rig providers in the Middle East market</li>
<li>Expects to maintain its high-quality investment grade credit rating</li>
<li>Adds complementary, asset-light global offshore management contract business and manufacturing and engineering operations in Europe and Middle East</li>
<li>H&amp;P to host a conference call to discuss its fiscal third quarter results and transaction today at 7:30 a.m. CT</li>
</ul>
Helmerich &amp; Payne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) ("H&amp;P" or the "Company") and KCA Deutag International Limited ("KCA Deutag") today announced a definitive agreement under which H&amp;P will acquire KCA Deutag for $1.9725 billion in cash.

Helmerich & Payne Announces Agreement To Acquire KCA Deutag For $1.9725B In Cash

Earnings

Helmerich & Payne Q3 2024 EPS $0.88 Vs $0.93 Est.; Total Revenue $698M Vs $664.9M Est

Helmerich &amp; Payne, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hp#NYSE">HP</a>) is set to release fiscal third-quarter earnings on Jul 24, after the closing bell. The current Zacks Consensus Estimate for earnings is pegged at 77 cents per share on revenues of $668.8 million.
Let&#39;s delve into the factors that might have influenced HP&#39;s performance in the to-be-reported quarter. Before that, it&#39;s worth taking a look at the company&#39;s performance in the last reported quarter.
<h3>Highlights of Q2 Earnings</h3>
In the last reported quarter, the Tulsa, OK-based oil and gas drilling company&#39;s earnings marginally beat the consensus mark. HP reported adjusted earnings of 86 cents per share, which was one cent higher than the Zacks Consensus Estimate. This was attributed to the strong performance of the International Solutions unit, which reported an operating profit of $3.6 million, surpassing the consensus estimate of a loss of $1.6 million.
Operating revenues of $687.9 million also beat the Zacks Consensus Estimate by 1.2%. HP&#39;s earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed the mark in one, delivering an average earnings surprise of 15.53%.
<div class="chart_embed">
<h3>Helmerich &amp; Payne, Inc. Price and EPS Surprise</h3>
<img alt="Helmerich &amp; Payne, Inc. Price and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/0b/1721381890.png" style="height:263px; width:538px" title="" />
Helmerich &amp; Payne, Inc. price-eps-surprise | Helmerich &amp; Payne, Inc. Quote
</div>
<h3>Trend in Estimate Revision</h3>
The Zacks Consensus Estimate for third-quarter fiscal 2024 earnings has witnessed an upward revision and no downward movement in the past 30 days. The estimated figure indicates a 29.36% year-over-year decline. The Zacks Consensus Estimate for revenues indicates a decrease of 7.61% from the year-ago period.
<h3>Factors to Consider</h3>
On a positive note, Helmerich &amp; Payne&lsquo;s operating costs and expenses are projected to have reached $559.5 million in the fiscal third quarter, down 2.7% from the year-ago period&#39;s level. Specifically, the company&#39;s drilling services and other operating expenses are expected to have reduced from $430.2 million to $386.9 million. This reduction in costs highlights the company&#39;s efforts to improve efficiency and control expenses.
On the other hand, HP&#39;s revenues are likely to have been negatively impacted in the quarter to be reported. Our model predicts fiscal third-quarter revenues to decrease to $666.1 million from the year-ago period&#39;s level of $724 million. This decline is due to the weaker performance across North America Solutions, International Solutions, Offshore Gulf of Mexico and Other segments, reflecting challenges in market conditions and segment-specific issues.
<h3>What Does Our Model Predict?</h3>
The proven Zacks model does not conclusively predict an earnings beat for Helmerich &amp; Payne this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. However, that&#39;s not the case here.
Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, for this company is +0.97%.
Zacks Rank:&nbsp; HP currently carries a Zacks Rank #5 (Strong Sell).
<h3>Stocks to Consider</h3>
Here are some firms that you may want to consider, as these have the right combination of elements to post an earnings beat this reporting cycle.
Coterra Energy (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctra#NYSE">CTRA</a>) has an Earnings ESP of +3.01% and a Zacks Rank #2 at present.
The firm is scheduled to release earnings on Aug 1. CTRA has a trailing four-quarter average earnings surprise of 9.81%. Valued at around $20.1 billion, CTRA&#39;s shares have risen 2.2% in a year.
Pembina Pipeline (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pba#NYSE">PBA</a>) currently has an Earnings ESP of +9.09% and a Zacks Rank #2. The firm is scheduled to release earnings on Aug 8.
PBA has a trailing four-quarter average earnings surprise of 10.91%. Valued at around $21.84 billion, PBA&#39;s shares have risen 21.9% in a year.
Baker Hughes (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bkr#NASDAQ">BKR</a>) has an Earnings ESP of +1.59% and a Zacks Rank #3 at present. The firm is scheduled to release earnings on Jul 25.
BKR has a trailing four-quarter average earnings surprise of 11.4%. &nbsp;Valued at around $36.09 billion, BKR&#39;s shares have risen 2% in a year.
<a href="https://www.zacks.com/stock/news/2305056/what-s-in-store-for-helmerich-payne-hp-in-q3-earnings?cid=CS-BENZ-FT-analyst_blog|earnings_preview-2305056">To read this article on Zacks.com click here.</a>

Earnings Beats

What's in Store for Helmerich & Payne in Q3 Earnings?

B of A Securities analyst Chase Mulvehill maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Buy and lowers the price target from $42.5 to $40.

B of A Securities Maintains Buy on Helmerich & Payne, Lowers Price Target to $40

Stocks with three weeks of deteriorating technicals by Piper Sandler

The Retiree's Taxable Dividend July 2024 Portfolio Review - New Record High Account Balance

Update on Oppenheimer's buy vs. sell SMID ideas from each of the sectors

CrowdStrike: Resilient Q2 Performance, Fragile FY25 Outlook

Intel resolves R2 litigation

Helmerich & Payne announces private offering of senior notes

Helmerich & Payne ( ($HP) ) has shared an update. Helmerich & Payne, Inc. is set to offer senior unsecured notes to qualified investors in a privat...

Helmerich & Payne Announces Unsecured Notes Amid Audit Challenges

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Helmerich & Payne

Helmerich & Payne (HP) Forecast

Helmerich & Payne (NYSE:HP) Stock, Quote.Headers.trade-ideas